Crossref
Lipoprotein(a) in Clinical Practice: From Risk Marker to Actionable Signal
Federal Practitioner · 03.11.2026 · 43 (Suppl 5)
DOI: 10.12788/fp.0780 ↗Kurz gefasst
Fachartikel in der Zeitschrift Federal Practitioner, online erschienen am 03.11.2026. Verfasst von Michael Shapiro.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Zitieren
APA
Shapiro, M. (2026). Lipoprotein(a) in Clinical Practice: From Risk Marker to Actionable Signal. Federal Practitioner, 43(Suppl 5). https://doi.org/10.12788/fp.0780
Vancouver
Shapiro M. Lipoprotein(a) in Clinical Practice: From Risk Marker to Actionable Signal. Federal Practitioner. 2026;43(Suppl 5). doi:10.12788/fp.0780
BibTeX
@article{Shapiro2026,
author = {Shapiro, Michael},
title = {Lipoprotein(a) in Clinical Practice: From Risk Marker to Actionable Signal},
journal = {Federal Practitioner},
year = {2026},
volume = {43},
number = {Suppl 5},
doi = {10.12788/fp.0780}
}
EUVIMED